Import Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M from China
Import trade data for Indian businesses
🇨🇳 China — Country Profile
Capital
Beijing
GDP (USD)
$18K
Population
1.4B
Currency
Renminbi
Trade Agreement
APTA
Import Snapshot
India imported $22.8M of antisera and other blood fractions and modified immunological products, whether or not obtained by m from China in 2024 — -58.8% YoY.
Based on HS Code 3002 import data (UN Comtrade)
Import History — China to India
2024
$22.8M
HS 3002 imports
2023
$55.3M
HS 3002 imports
2022
$15.5M
HS 3002 imports
About Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M Imports from China
China is one of the supplying countries for antisera and other blood fractions and modified immunological products, whether or not obtained by m to the Indian market, classified under HS heading 3002. Indian importers source this product for domestic consumption, manufacturing inputs, or re-export.
Other Countries Supplying Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M to India
Import Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M from China
Get expert guidance on sourcing, customs procedures, and compliance.
Contact XIMPEX